surmount 3 tirzepatide for the treatment of obesity: Rationale and design of the clinical development program - Roux - 2023 - Obesity Diabetes Dialogue: SURMOUNT-3 and -4

Lauren Nawrocki and our experienced team tailor your semaglutide dosing to minimize side effects while maximizing your weight loss results

But experts believe it may help with some underlying factors that can contribute to weight gain in some people

It is not intended for human or veterinary use, diagnosis, or therapeutic application

Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly prescribed medications for type 2 diabetes and weight management in the UK

People who remain sedentary still lose weight through caloric deficit but experience less favorable body composition changes and slower overall progress